The Utilization of the Multimodal Immunotherapy for the Opsoclonus–myoclonus Syndrome Can Reduce Relapses and Permanent Neurological Sequelae
Italian Journal of Pediatrics（2025）
Key words
Opsoclonus–Myoclonus syndrome,Multimodal therapy,Intravenous dexamethasone,Rituximab,Intravenous immunoglobulin,Relapses,Permanent neurological sequelae
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined